Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Curr Opin Neurol. 2022 Apr 1;35(2):240–248. doi: 10.1097/WCO.0000000000001041

Fig 1A.

Fig 1A.

Study Design. Participants are randomized into the novel or established group. The novel group completes the NPE battery and the CFAS at baseline, 3 months, and 12 months. The established group completes the PACC, ADAS-cog, and FAQ at baseline, 3 months, and 12 months. Both groups undergo MRI and have plasma biomarkers drawn at baseline and 12 months.